-
Recent Posts
- Investors Encouraged by Preliminary Results of Drug Study from MediciNova, Inc. (NASDAQ: MNOV)
- Can Axiologix, Inc. (PINKSHEETS: AXLX) Turn Definitive Agreement into an Actual Acquisition?
- Gevo, Inc. (NASDAQ: GEVO) Gets Big Boost Following Resumption of Isobutanol Production
- Will Generex Biotechnology Corp. (OTCQB: GNBT) Advance Breast Cancer Treatment to the Next Stage?
- Amicus Therapeutics, Inc. (NASDAQ: FOLD) Taking a Hit Following FDA Decision
Categories
OTC Equity Archives
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
Tags
aapl advertising alternative energy amex apple basic materials biopharmaceutical biotechnology cancer capital goods china cloud computing copper drilling energy energy stocks exploration facebook fda gas gold gold mining google healthcare healthcare stocks investors ipad iphone medical marijuana mining NASDAQ natural gas nyse oil oil and gas otcbb penny stock penny stocks pharmaceutical pinksheets Pink Sheets s silver sprint stocksSite
OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.
Registration to our newsletter is FREE, Join today by entering your email below!
Tag Archives: investors
Investors Encouraged by Preliminary Results of Drug Study from MediciNova, Inc. (NASDAQ: MNOV)
MediciNova, Inc. (NASDAQ: MNOV) has certainly seen some wild swings in their share price over the past few months, trading as low as 2.26 in April only to climb to a 52-week high of 4.70 in May, then dipping down … Continue reading
Posted in Articles, NASDAQ
Tagged addiction, biopharmaceutical, drug study, fda, investors, medicinova, methamphetamine, mnov, opioid
Leave a comment
Can Axiologix, Inc. (PINKSHEETS: AXLX) Turn Definitive Agreement into an Actual Acquisition?
Back in late February Axiologix, Inc. (PINKSHEETS: AXLX) announced they had “completed a Letter of Intent to acquire 100% of a leading California based provider of IP voice, data and managed services to small and medium enterprises (SMEs) across the … Continue reading
Posted in Uncategorized
Tagged axiologix, axlx, cloud computing, investors, ip voice and data services, network factor, voip
Leave a comment
Gevo, Inc. (NASDAQ: GEVO) Gets Big Boost Following Resumption of Isobutanol Production
With news that Gevo, Inc. (NASDAQ: GEVO) had restarted commercial production of isobutanol at its plant in Minnesota trading activity in the renewable chemicals and next-generation biofuels company spiked considerably on Tuesday with more than 8.6 million shares moving hands … Continue reading
Posted in Articles, NASDAQ
Tagged biofuels, fermentation, fuel blendstock, gevo, investors, isobutanol, jet, renewable chemicals
Leave a comment
Will Generex Biotechnology Corp. (OTCQB: GNBT) Advance Breast Cancer Treatment to the Next Stage?
After trading as low as 0.0253 on May 21, 2013 shares of Generex Biotechnology Corp. (OTCQB: GNBT) saw a steady climb into the first few days of June and hit a high of 0.0430 before sliding back to a low … Continue reading
Posted in Uncategorized
Tagged breast cancer, cancer treatment, drug delivery, fda, generex biotechnology, gnbt, investors, oral
Leave a comment
Amicus Therapeutics, Inc. (NASDAQ: FOLD) Taking a Hit Following FDA Decision
With no products on the market Amicus Therapeutics, Inc. (NASDAQ: FOLD) was certainly hoping that the FDA would accept their request to amend the statistical plan created for the Phase III study of their experimental drug Amigal used to treat … Continue reading
Posted in NASDAQ
Tagged amicus therapeutics, amigal, drugs, fabry disease, fda, fold, glaxosmithkline, investors, kidneys
Leave a comment
Titan Energy Worldwide, Inc. (OTCQB: TEWI) Generating Strong Revenue but can they become Profitable?
It has been nearly two weeks since Titan Energy Worldwide, Inc. (OTCQB: TEWI) announced that they had posted record sales of more than $2.6 million for the month of April yet it was only today that the distributer of power … Continue reading
Posted in Uncategorized
Tagged energy, energy management, investors, power distribution, power generation, tewi, titan energy
Leave a comment
Belo Corp. (NYSE: BLC) Soaring Following Announced Deal with Gannett Co., Inc. (NYSE: GCI)
Trading activity surrounding Belo Corp. (NYSE: BLC) continues to climb following news this morning that Gannett Co., Inc. (NYSE: GCI) had struck a deal with the television company that has been reportedly worth $1.5 billion. BLC closed yesterday’s session at … Continue reading
Posted in Articles, NYSE
Tagged a.h. belo, belo corp, blc, broadcasting, fcc, gannett, gci, investors, newspaper, shive, television
Leave a comment
Is Ghana Gold Corp. (PINKSHEETS: GGCO) Capable of Generating Meaningful Gold Production?
The rather wild swings of Ghana Gold Corp. (PINKSHEETS: GGCO) over the last three months has unquestionably made some investors a significant amount of money but on the flip side it has left just as many, if not more, staring … Continue reading
Posted in Uncategorized
Tagged ggco, ghana gold, gold, gold mining, gold production, gold property, investors, recoverable gold
Leave a comment
Can Purchase Orders Propel Share Price of Inova Technology, Inc. (OTCQB: INVA)?
Investors who are fans of heavy trading volume must love Inova Technology, Inc. (OTCQB: INVA) as the enterprise level Information Technology solutions provider specializing in providing proprietary RFID solutions, wireless networking, storage and security technology solutions and IT professional services … Continue reading
Posted in Uncategorized
Tagged information technology, inova technology, inva, investors, rfid solutions, wireless networking
Leave a comment
Can Dendreon Corporation (NASDAQ: DNDN) Fight Off Competition and Rebound from Disappointing First Quarter?
Investors who have been trying to get an accurate read on what’s happening with Dendreon Corporation (NASDAQ: DNDN) have no doubt been frustrated by the inconsistency of the biotechnology company’s share price as it has experienced considerable shifts over the … Continue reading
Posted in Articles, NASDAQ
Tagged biotechnology, cancer drug, dendreon corp, dndn, investors, mdvn, nvs, prostate cancer, provenge
Leave a comment


